ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000211593 | IGKJ5 | Immunoglobulin kappa joining 5 | [] | 2 | 88860568-88860605 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 43: Hindbrain - Mixed function | Cluster 46: Lymphoma - Humoral immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 4 | Group enriched | Detected in some | 12 | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in all | 24 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,466 | 4 |
ENSG00000211595 | IGKJ3 | Immunoglobulin kappa joining 3 | [] | 2 | 88861221-88861258 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 7: Non-specific - Ribosome | Cluster 51: Myeloma - Immunoglobulins | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 18 | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in all | 25 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,468 | 9 |
ENSG00000211596 | IGKJ2 | Immunoglobulin kappa joining 2 | [] | 2 | 88861525-88861563 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"J2"
] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 18: Non-specific - Mixed function | Cluster 46: Lymphoma - Humoral immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 10 | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in all | 50 | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 17,469 | 1 |
ENSG00000211597 | IGKJ1 | Immunoglobulin kappa joining 1 | [
"A0A0A0MT89"
] | 2 | 88861886-88861923 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"J1"
] | [
"Immunoglobulin genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 20: Myeloma - Immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 5 | Group enriched | Detected in many | 20 | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in all | 418 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma"
] | 17,470 | 3 |
ENSG00000211598 | IGKV4-1 | Immunoglobulin kappa variable 4-1 | [
"P06312"
] | 2 | 88885397-88886153 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"B3",
"IGKV41"
] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 11 | Cancer enhanced | Detected in all | null | Cell type enriched | Detected in some | 40 | Group enriched | Detected in many | 590 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,471 | 3 |
ENSG00000211599 | IGKV5-2 | Immunoglobulin kappa variable 5-2 | [
"P06315"
] | 2 | 88897232-88897784 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"B2",
"IGKV52"
] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in single | 24 | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in single | 25 | Group enriched | Detected in some | 19 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,472 | 9 |
ENSG00000211611 | IGKV6-21 | Immunoglobulin kappa variable 6-21 (non-functional) | [
"A0A0C4DH24"
] | 2 | 89159751-89160366 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [
"A26",
"IGKV621"
] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 20: Myeloma - Immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in single | 9 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 195 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 17,473 | 5 |
ENSG00000211623 | IGKV2D-26 | Immunoglobulin kappa variable 2D-26 | [
"A0A0A0MRZ7"
] | 2 | 89985922-89986702 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | Cluster 29: Forebrain - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 19 | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in some | 246 | 0 | 0 | 0 | [] | [] | [] | 17,474 | 8 |
ENSG00000211625 | IGKV3D-20 | Immunoglobulin kappa variable 3D-20 | [
"A0A0C4DH25"
] | 2 | 90038848-90039479 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA047702"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | Approved | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 12: Non-specific - Vasculature | Cluster 51: Myeloma - Immunoglobulins | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 711 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 1,034 | 1 | 0 | 1 | [
"Bladder Urothelial Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma"
] | 17,475 | 7 |
ENSG00000211626 | IGKV6D-41 | Immunoglobulin kappa variable 6D-41 (non-functional) | [
"A0A0C4DH26"
] | 2 | 90069662-90070238 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 13 | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Group enriched | Detected in some | 40 | 0 | 0 | 0 | [] | [] | [] | 17,476 | 7 |
ENSG00000211632 | IGKV3D-11 | Immunoglobulin kappa variable 3D-11 | [
"A0A0A0MRZ8"
] | 2 | 90172802-90173414 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA047702"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | Approved | Approved | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 317 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 6 | Group enriched | Detected in some | 469 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,477 | 4 |
ENSG00000211633 | IGKV1D-42 | Immunoglobulin kappa variable 1D-42 (non-functional) | [
"A0A075B6H8"
] | 2 | 90190193-90190681 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA048721"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 55: Lymphoma - Immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in some | 37 | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 17,478 | 1 |
ENSG00000211637 | IGLV4-69 | Immunoglobulin lambda variable 4-69 | [
"A0A075B6H9"
] | 22 | 22030934-22031472 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 4 | Cancer enriched | Detected in single | 405 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 10 | Group enriched | Detected in some | 301 | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 17,479 | 9 |
ENSG00000211638 | IGLV8-61 | Immunoglobulin lambda variable 8-61 | [
"A0A075B6I0"
] | 22 | 22098700-22099212 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 14: Non-specific - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 6 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 8 | Group enriched | Detected in some | 633 | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 17,480 | 1 |
ENSG00000211639 | IGLV4-60 | Immunoglobulin lambda variable 4-60 | [
"A0A075B6I1"
] | 22 | 22162199-22162681 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 55: Lymphoma - Immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 16 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in single | 14 | Group enriched | Detected in some | 77 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 17,481 | 6 |
ENSG00000211640 | IGLV6-57 | Immunoglobulin lambda variable 6-57 | [
"P01721"
] | 22 | 22195799-22196276 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028862"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Supported | null | 8 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 49: Hindbrain - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 6 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 44 | Group enriched | Detected in some | 11 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 17,482 | 9 |
ENSG00000211641 | IGLV11-55 | Immunoglobulin lambda variable 11-55 (non-functional) | [
"A0A075B6I3"
] | 22 | 22201663-22202161 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | null | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in single | null | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Cell type enriched | Detected in single | 8 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 17,483 | 7 |
ENSG00000211642 | IGLV10-54 | Immunoglobulin lambda variable 10-54 | [
"A0A075B6I4"
] | 22 | 22214794-22215270 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 7 | Not detected | Not detected | null | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 6 | Group enriched | Detected in some | 32 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 17,484 | 1 |
ENSG00000211643 | IGLV5-52 | Immunoglobulin lambda variable 5-52 | [
"A0A0A0MRZ9"
] | 22 | 22318727-22319226 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 14: Non-specific - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 6: Leukemia - Signal transduction | null | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in many | 6 | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 17,485 | 6 |
ENSG00000211644 | IGLV1-51 | Immunoglobulin lambda variable 1-51 | [
"P01701"
] | 22 | 22322472-22322969 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 37: Neurons - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in all | null | Group enriched | Detected in many | 52 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 14 | Group enriched | Detected in some | 9 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,486 | 8 |
ENSG00000211645 | IGLV1-50 | Immunoglobulin lambda variable 1-50 (non-functional) | [
"A0A075B6I6"
] | 22 | 22327300-22327814 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 37: Neurons - Mixed function | Cluster 51: Myeloma - Immunoglobulins | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 7 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in some | 21 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 17,487 | 4 |
ENSG00000211647 | IGLV5-48 | Immunoglobulin lambda variable 5-48 (non-functional) | [
"A0A075B6I7"
] | 22 | 22352940-22353433 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in single | null | Low cancer specificity | Detected in some | null | Cell type enriched | Detected in single | 10 | Group enriched | Detected in some | 62 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 17,488 | 3 |
ENSG00000211648 | IGLV1-47 | Immunoglobulin lambda variable 1-47 | [
"P01700"
] | 22 | 22357739-22358260 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 235 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 9 | Group enriched | Detected in some | 639 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,489 | 6 |
ENSG00000211649 | IGLV7-46 | Immunoglobulin lambda variable 7-46 | [
"A0A075B6I9"
] | 22 | 22369614-22370087 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA003182"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in single | 5 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 5 | Group enriched | Detected in some | 378 | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 17,490 | 4 |
ENSG00000211650 | IGLV5-45 | Immunoglobulin lambda variable 5-45 | [
"A0A087WSX0"
] | 22 | 22375986-22376505 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | null | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 5: Spleen - Immune response | Group enriched | Detected in many | 4 | Cancer enriched | Detected in single | 16 | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 11 | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 17,491 | 1 |
ENSG00000211651 | IGLV1-44 | Immunoglobulin lambda variable 1-44 | [
"P01699"
] | 22 | 22380766-22381347 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 43: Hindbrain - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 164 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 839 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,492 | 6 |
ENSG00000211652 | IGLV7-43 | Immunoglobulin lambda variable 7-43 | [
"P04211"
] | 22 | 22395018-22395489 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA003182"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 10: Ciliated cells - Ion channel activity | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in single | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 324 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,493 | 6 |
ENSG00000211653 | IGLV1-40 | Immunoglobulin lambda variable 1-40 | [
"P01703"
] | 22 | 22409766-22410282 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 14 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 493 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma"
] | 17,494 | 5 |
ENSG00000211654 | IGLV5-37 | Immunoglobulin lambda variable 5-37 | [
"A0A075B6J1"
] | 22 | 22427540-22428035 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | null | Cluster 55: Lymphoma - Immune response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in some | 5 | Not detected | Not detected | null | Cancer enhanced | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in some | 54 | 1 | 0 | 1 | [
"Rectum Adenocarcinoma"
] | [] | [
"Rectum Adenocarcinoma"
] | 17,495 | 5 |
ENSG00000211655 | IGLV1-36 | Immunoglobulin lambda variable 1-36 | [
"A0A0B4J1U3"
] | 22 | 22431958-22432465 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | null | Cluster 55: Lymphoma - Immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 45 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 625 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 17,496 | 5 |
ENSG00000211656 | IGLV2-33 | Immunoglobulin lambda variable 2-33 (non-functional) | [
"A0A075B6J2"
] | 22 | 22588155-22588688 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 20: Myeloma - Immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in some | 25 | 0 | 0 | 0 | [] | [] | [] | 17,497 | 8 |
ENSG00000211658 | IGLV3-27 | Immunoglobulin lambda variable 3-27 | [
"P01718"
] | 22 | 22668288-22668806 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in many | 7 | Not detected | Not detected | null | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in single | 8 | Group enriched | Detected in some | 720 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,499 | 6 |
ENSG00000211659 | IGLV3-25 | Immunoglobulin lambda variable 3-25 | [
"P01717"
] | 22 | 22686726-22687271 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003285"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 14 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 45 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,500 | 5 |
ENSG00000211660 | IGLV2-23 | Immunoglobulin lambda variable 2-23 | [
"P01705"
] | 22 | 22697789-22698407 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 24 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 7 | Group enriched | Detected in many | 368 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 17,501 | 8 |
ENSG00000211661 | IGLV3-22 | Immunoglobulin lambda variable 3-22 | [
"A0A075B6J6"
] | 22 | 22704265-22704822 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 11 | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in some | 72 | 0 | 0 | 0 | [] | [] | [] | 17,502 | 9 |
ENSG00000211662 | IGLV3-21 | Immunoglobulin lambda variable 3-21 | [
"P80748"
] | 22 | 22711689-22713203 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 15 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 8 | Group enriched | Detected in some | 337 | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,503 | 3 |
ENSG00000211663 | IGLV3-19 | Immunoglobulin lambda variable 3-19 | [
"P01714"
] | 22 | 22720623-22721145 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 22: Non-specific - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in single | 272 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 4 | Group enriched | Detected in some | 353 | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 17,504 | 3 |
ENSG00000211664 | IGLV2-18 | Immunoglobulin lambda variable 2-18 | [
"A0A075B6J9"
] | 22 | 22734607-22735089 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 1,869 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 4 | Group enriched | Detected in many | 44 | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 17,505 | 2 |
ENSG00000211665 | IGLV3-16 | Immunoglobulin lambda variable 3-16 | [
"A0A075B6K0"
] | 22 | 22747383-22747921 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 5 | Cancer enriched | Detected in single | 398 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 394 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,506 | 8 |
ENSG00000211666 | IGLV2-14 | Immunoglobulin lambda variable 2-14 | [
"P01704"
] | 22 | 22758700-22759218 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 10 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 6 | Group enriched | Detected in all | 51 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 17,507 | 3 |
ENSG00000211667 | IGLV3-12 | Immunoglobulin lambda variable 3-12 | [
"A0A075B6K2"
] | 22 | 22771824-22772582 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 5 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,508 | 7 |
ENSG00000211668 | IGLV2-11 | Immunoglobulin lambda variable 2-11 | [
"P01706"
] | 22 | 22792491-22793007 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 12 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 6 | Group enriched | Detected in many | 37 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma"
] | 17,509 | 6 |
ENSG00000211669 | IGLV3-10 | Immunoglobulin lambda variable 3-10 | [
"A0A075B6K4"
] | 22 | 22811747-22812281 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA003285"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 12: Non-specific - Vasculature | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 67 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 9 | Group enriched | Detected in some | 785 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,510 | 9 |
ENSG00000211670 | IGLV3-9 | Immunoglobulin lambda variable 3-9 | [
"A0A075B6K5"
] | 22 | 22819010-22819756 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA003285"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 18: Non-specific - Mixed function | Cluster 20: Myeloma - Immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 4 | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 4 | Group enriched | Detected in many | 52 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,511 | 6 |
ENSG00000211672 | IGLV4-3 | Immunoglobulin lambda variable 4-3 | [
"A0A075B6K6"
] | 22 | 22871507-22872035 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 34: B-cells - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in some | 4 | Group enriched | Detected in some | 35 | Cancer enhanced | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in some | 98 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,512 | 5 |
ENSG00000211673 | IGLV3-1 | Immunoglobulin lambda variable 3-1 | [
"P01715"
] | 22 | 22880706-22881396 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003285"
] | [] | [
"Immunoglobulin genes",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 4 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in some | 24 | Group enriched | Detected in some | 728 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,513 | 8 |
ENSG00000211676 | IGLJ2 | Immunoglobulin lambda joining 2 | [] | 22 | 22899481-22899655 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 43: Hindbrain - Mixed function | Cluster 51: Myeloma - Immunoglobulins | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 10 | Cancer enhanced | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 12 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma"
] | 17,516 | 8 |
ENSG00000211677 | IGLC2 | Immunoglobulin lambda constant 2 | [
"P0DOY2"
] | 22 | 22900976-22901437 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"IGLC"
] | [
"Immunoglobulin genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Bence-Jones protein"
] | [] | [] | [] | [
"Immunoglobulin genes"
] | [
"Immunity"
] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 20: Myeloma - Immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 10 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 9 | Group enriched | Detected in all | 36 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,517 | 6 |
ENSG00000211678 | IGLJ3 | Immunoglobulin lambda joining 3 | [] | 22 | 22904850-22905025 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 7 | Cancer enriched | Detected in some | 7 | Cancer enhanced | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in many | 24 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 17,518 | 8 |
ENSG00000211680 | IGLJ4 | Immunoglobulin lambda joining 4 (non-functional) | [] | 22 | 22910574-22910606 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 54: Immune cells - T cell receptor | Cluster 46: Lymphoma - Humoral immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in some | 30 | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 17,520 | 7 |
ENSG00000211681 | IGLJ5 | Immunoglobulin lambda joining 5 (non-functional) | [] | 22 | 22914237-22914308 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | null | Cluster 46: Lymphoma - Humoral immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 9 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 118 | 0 | 0 | 0 | [] | [] | [] | 17,521 | 9 |
ENSG00000211684 | IGLJ7 | Immunoglobulin lambda joining 7 | [] | 22 | 22921390-22921435 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 14: Non-specific - Unknown function | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 46: Lymphoma - Humoral immune response | null | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 64 | Cancer enhanced | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in some | 222 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,523 | 5 |
ENSG00000211685 | IGLC7 | Immunoglobulin lambda constant 7 | [] | 22 | 22922594-22923034 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [] | [
"Immunoglobulin genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Immunoglobulin genes"
] | [] | null | null | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 51: Myeloma - Immunoglobulins | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 24 | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 11 | Group enriched | Detected in some | 244 | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,524 | 3 |
ENSG00000211687 | TRGJ2 | T cell receptor gamma joining 2 | [] | 7 | 38253380-38253429 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"J2",
"TCRGJ2"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 59: Leukemia - T-cell receptor | null | Cluster 38: Non-specific - Basic cellular processes | Group enriched | Detected in some | 6 | Cancer enriched | Detected in some | 4 | Cancer enriched | Detected in single | 53 | Not detected | Not detected | null | Group enriched | Detected in many | 5 | 0 | 0 | 0 | [] | [] | [] | 17,525 | 4 |
ENSG00000211688 | TRGJP2 | T cell receptor gamma joining P2 | [] | 7 | 38256337-38256396 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"JP2",
"TCRGJP2"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 15: NK-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 14: Myeloid leukemia - Innate immune response | null | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 4 | Cancer enriched | Detected in some | 11 | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,526 | 6 |
ENSG00000211689 | TRGC1 | T cell receptor gamma constant 1 | [] | 7 | 38257879-38265678 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"C1",
"TCRGC1"
] | [
"Predicted membrane proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 15: NK-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 60: Prostate cancer - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 15: Bone marrow - Innate immune response | Group enriched | Detected in some | 8 | Group enriched | Detected in some | 10 | Cancer enriched | Detected in some | 25 | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,527 | 8 |
ENSG00000211690 | TRGJ1 | T cell receptor gamma joining 1 | [
"A0A075B6S0"
] | 7 | 38269491-38269540 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"J1",
"TCRGJ1"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 59: Leukemia - T-cell receptor | null | Cluster 38: Non-specific - Basic cellular processes | Group enriched | Detected in some | 6 | Cancer enriched | Detected in some | 4 | Cancer enriched | Detected in single | 53 | Not detected | Not detected | null | Group enriched | Detected in many | 5 | 0 | 0 | 0 | [] | [] | [] | 17,528 | 7 |
ENSG00000211691 | TRGJP | T cell receptor gamma joining P | [] | 7 | 38273587-38273647 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"JP",
"TCRGJP"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 15: NK-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 14: Myeloid leukemia - Innate immune response | null | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in some | 10 | Not detected | Not detected | null | Cancer enriched | Detected in some | 23 | Not detected | Not detected | null | Immune cell enriched | Detected in many | 38 | 0 | 0 | 0 | [] | [] | [] | 17,529 | 7 |
ENSG00000211693 | TRGV11 | T cell receptor gamma variable 11 (non-functional) | [
"A0A075B6L2"
] | 7 | 38291616-38292078 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV11",
"V4P"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 24: Non-specific - Transcription | null | Cluster 60: Prostate cancer - Unknown function | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Immune cell enriched | Detected in single | 7 | 0 | 0 | 0 | [] | [] | [] | 17,531 | 2 |
ENSG00000211695 | TRGV9 | T cell receptor gamma variable 9 | [
"Q99603"
] | 7 | 38317017-38318861 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV9",
"V2"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 15: NK-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 60: Prostate cancer - Unknown function | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 19 | Cancer enriched | Detected in single | 66 | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in many | 13 | 0 | 0 | 0 | [] | [] | [] | 17,533 | 6 |
ENSG00000211696 | TRGV8 | T cell receptor gamma variable 8 | [
"A0A0C4DH27"
] | 7 | 38330343-38330935 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV8",
"V1S8"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | Cluster 49: Hindbrain - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 16 | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 6 | 0 | 0 | 0 | [] | [] | [] | 17,534 | 5 |
ENSG00000211697 | TRGV5 | T cell receptor gamma variable 5 | [
"A0A0B4J1U4"
] | 7 | 38349355-38350022 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV5",
"V1S5"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,535 | 4 |
ENSG00000211698 | TRGV4 | T cell receptor gamma variable 4 | [
"A0A0C4DH28"
] | 7 | 38353715-38354517 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV4",
"V1S4"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 8 | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in single | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,536 | 5 |
ENSG00000211699 | TRGV3 | T cell receptor gamma variable 3 | [
"P03979"
] | 7 | 38358512-38359162 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRGV3",
"V1S3"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | 29 | null | null | Cluster 1: T-cells - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 8 | Low cancer specificity | Detected in some | null | Cell type enriched | Detected in single | 4 | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,537 | 6 |
ENSG00000211706 | TRBV6-1 | T cell receptor beta variable 6-1 | [
"A0A0K0K1D8"
] | 7 | 142328297-142328786 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV13S3",
"TCRBV6S1",
"TRBV61"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 11: Neuronal - Sensory perception | null | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 49 | Not detected | Not detected | null | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,539 | 8 |
ENSG00000211710 | TRBV4-1 | T cell receptor beta variable 4-1 | [
"A0A577"
] | 7 | 142313184-142313666 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"BV07S1J2.7",
"TCRBV4S1",
"TCRBV7S1A1N2T",
"TRBV41"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 26 | Cancer enriched | Detected in single | 55 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 17,541 | 9 |
ENSG00000211714 | TRBV7-3 | T cell receptor beta variable 7-3 | [
"A0A075B6L6"
] | 7 | 142384329-142384841 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV6S1A1N1",
"TCRBV7S3",
"TRBV73"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 71: Lymphoma - Inflammatory response | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 80: Thymus - Adaptive immune response | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 41 | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,543 | 6 |
ENSG00000211717 | TRBV10-1 | T cell receptor beta variable 10-1 | [
"A0A0K0K1A3"
] | 7 | 142399860-142400377 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV10S1",
"TCRBV12S2",
"TCRBV12S2A1T",
"TRBV101"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 11: T-cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | null | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in single | 13 | Cancer enriched | Detected in single | 21 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in many | 9 | 0 | 0 | 0 | [] | [] | [] | 17,546 | 7 |
ENSG00000211721 | TRBV6-5 | T cell receptor beta variable 6-5 | [
"A0A0K0K1A5"
] | 7 | 142450947-142451448 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV13S1",
"TCRBV6S5",
"TRBV65"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | null | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 11 | Cancer enriched | Detected in single | 82 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,548 | 8 |
ENSG00000211724 | TRBV6-6 | T cell receptor beta variable 6-6 | [
"A0A0A6YYG2"
] | 7 | 142469537-142470013 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV13S6A2T",
"TCRBV6S6",
"TRBV66"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 7 | Cancer enriched | Detected in single | 37 | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,549 | 1 |
ENSG00000211725 | TRBV5-5 | T cell receptor beta variable 5-5 | [
"A0A597"
] | 7 | 142482548-142483019 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV5S3A2T",
"TCRBV5S5",
"TRBV55"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in single | 26 | Cancer enriched | Detected in single | 150 | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Group enriched | Detected in many | 25 | 0 | 0 | 0 | [] | [] | [] | 17,550 | 8 |
ENSG00000211727 | TRBV7-6 | T cell receptor beta variable 7-6 | [
"A0A1B0GX31"
] | 7 | 142492132-142492673 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV6S3A1N1T",
"TCRBV7S6",
"TRBV76"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 70: DU4475 - Unknown function | null | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 7 | Not detected | Not detected | null | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in many | 22 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 17,551 | 3 |
ENSG00000211728 | TRBV5-6 | T cell receptor beta variable 5-6 | [
"A0A599"
] | 7 | 142500028-142500534 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV5S2",
"TCRBV5S6",
"TRBV56"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 19 | Cancer enriched | Detected in single | 439 | Low cancer specificity | Detected in single | null | Cell type enhanced | Detected in single | null | Group enriched | Detected in many | 14 | 0 | 0 | 0 | [] | [] | [] | 17,552 | 1 |
ENSG00000211731 | TRBV5-7 | T cell receptor beta variable 5-7 (non-functional) | [
"A0A0A0MS05"
] | 7 | 142520090-142520556 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV5S7",
"TCRBV5S7P",
"TRBV57"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Immune cell enhanced | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 17,553 | 6 |
ENSG00000211734 | TRBV5-1 | T cell receptor beta variable 5-1 | [
"A0A578"
] | 7 | 142320677-142321544 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV5S1",
"TCRBV5S1A1T",
"TRBV51"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | null | Cluster 11: Neuronal - Sensory perception | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 23 | Not detected | Not detected | null | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,554 | 6 |
ENSG00000211745 | TRBV4-2 | T cell receptor beta variable 4-2 | [
"A0A539"
] | 7 | 142345421-142345985 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [
"TCRBV4S2",
"TCRBV7S3A2T",
"TRBV42"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 1: T-cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | null | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 14 | Cancer enriched | Detected in single | 235 | Not detected | Not detected | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,555 | 5 |
ENSG00000211746 | TRBV19 | T cell receptor beta variable 19 | [
"A0A075B6N1"
] | 7 | 142618849-142619532 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV17S1A1T",
"TCRBV19S1"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 14 | Cancer enriched | Detected in single | 14 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 4 | 0 | 0 | 0 | [] | [] | [] | 17,556 | 2 |
ENSG00000211747 | TRBV20-1 | T cell receptor beta variable 20-1 | [
"A0A075B6N2"
] | 7 | 142626649-142627399 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [
"TCRBV20S1",
"TCRBV2S1",
"TRBV201"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 49: Hindbrain - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 27 | Cancer enriched | Detected in some | 79 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,557 | 1 |
ENSG00000211749 | TRBV23-1 | T cell receptor beta variable 23-1 (non-functional) | [
"A0A0A0MS06"
] | 7 | 142645961-142646467 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV19S1P",
"TCRBV23S1",
"TRBV231"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 11: T-cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 5 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Low immune cell specificity | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 17,558 | 5 |
ENSG00000211750 | TRBV24-1 | T cell receptor beta variable 24-1 | [
"A0A075B6N3"
] | 7 | 142656701-142657213 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBV15S1",
"TCRBV24S1",
"TRBV241"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 33: Neurons - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 4 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,559 | 8 |
ENSG00000211751 | TRBC1 | T cell receptor beta constant 1 | [
"P01850"
] | 7 | 142791694-142793368 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"BV05S1J2.2",
"TCRBC1"
] | [
"Predicted membrane proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 8: Immune cells - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in many | 28 | Cancer enriched | Detected in some | 6 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 11 | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,560 | 4 |
ENSG00000211752 | TRBV27 | T cell receptor beta variable 27 | [
"A0A0K0K1C4"
] | 7 | 142715346-142715861 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [
"TCRBV14S1",
"TCRBV27S1"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 33: Neurons - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 14 | Cancer enriched | Detected in single | 6 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 8 | 1 | 0 | 1 | [
"Skin Cutaneous Melanoma"
] | [] | [
"Skin Cutaneous Melanoma"
] | 17,561 | 8 |
ENSG00000211753 | TRBV28 | T cell receptor beta variable 28 | [
"A0A5B6"
] | 7 | 142720660-142721160 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBV28S1",
"TCRBV3S1"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | null | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 38 | Cancer enriched | Detected in single | 9 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,562 | 3 |
ENSG00000211764 | TRBJ2-1 | T cell receptor beta joining 2-1 | [
"A0A0A0MTA7"
] | 7 | 142796365-142796414 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBJ2S1",
"TRBJ21"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 51: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 5 | Cancer enriched | Detected in many | 4 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 17,563 | 3 |
ENSG00000211765 | TRBJ2-2 | T cell receptor beta joining 2-2 | [] | 7 | 142796560-142796610 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"TCRBJ2S2",
"TRBJ22"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 4 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 7 | 0 | 0 | 0 | [] | [] | [] | 17,564 | 3 |
ENSG00000211766 | TRBJ2-2P | T cell receptor beta joining 2-2P (non-functional) | [] | 7 | 142796697-142796742 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"TRBJ22P"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in all | 28 | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 17,565 | 6 |
ENSG00000211767 | TRBJ2-3 | T cell receptor beta joining 2-3 | [
"A0A0B4J200"
] | 7 | 142796847-142796895 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at transcript level | [] | [
"TCRBJ2S3",
"TRBJ23"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Low cancer specificity | Detected in all | null | Not detected | Not detected | null | Group enriched | Detected in all | 12 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,566 | 2 |
ENSG00000211768 | TRBJ2-4 | T cell receptor beta joining 2-4 | [] | 7 | 142796998-142797047 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"TCRBJ2S4",
"TRBJ24"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 39: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 6 | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,567 | 2 |
ENSG00000211769 | TRBJ2-5 | T cell receptor beta joining 2-5 | [] | 7 | 142797119-142797166 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"TCRBJ2S5",
"TRBJ25"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 53: Neurons - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 51: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in some | 6 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,568 | 7 |
ENSG00000211770 | TRBJ2-6 | T cell receptor beta joining 2-6 | [] | 7 | 142797239-142797291 | Evidence at transcript level | Evidence at transcript level | null | null | [] | [
"TCRBJ2S6",
"TRBJ26"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 39: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,569 | 2 |
ENSG00000211771 | TRBJ2-7 | T cell receptor beta joining 2-7 | [
"A0A0A0MT78"
] | 7 | 142797456-142797502 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [
"TCRBJ2S7",
"TRBJ27"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | null | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in all | 7 | 0 | 0 | 0 | [] | [] | [] | 17,570 | 6 |
ENSG00000211772 | TRBC2 | T cell receptor beta constant 2 | [
"A0A5B9"
] | 7 | 142801041-142802748 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRBC2"
] | [
"Predicted membrane proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 43: Non-specific - Transcription & Translation | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 66: Lymphoid tissue - Immune response | Group enriched | Detected in many | 5 | Cancer enriched | Detected in single | 15 | Low cancer specificity | Detected in single | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 17,571 | 3 |
ENSG00000211776 | TRAV2 | T cell receptor alpha variable 2 | [
"A0A0B4J234"
] | 14 | 21712321-21712843 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 20 | Group enriched | Detected in some | 5 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,572 | 4 |
ENSG00000211777 | TRAV3 | T cell receptor alpha variable 3 | [
"A0A0B4J244"
] | 14 | 21723713-21724321 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 7 | Group enriched | Detected in some | 20 | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in single | null | Group enriched | Detected in many | 4 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 17,573 | 3 |
ENSG00000211778 | TRAV4 | T cell receptor alpha variable 4 | [
"A0A0B4J268"
] | 14 | 21736152-21736982 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TCRAV20S1",
"TCRAV4S1"
] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 11 | Group enriched | Detected in some | 50 | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 7 | Group enriched | Detected in many | 70 | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 17,574 | 2 |
ENSG00000211779 | TRAV5 | T cell receptor alpha variable 5 | [
"A0A0B4J249"
] | 14 | 21749178-21749705 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 8: Immune cells - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 4 | Group enriched | Detected in some | 9 | Low cancer specificity | Detected in some | null | Cell type enriched | Detected in single | 12 | Group enriched | Detected in many | 51 | 0 | 0 | 0 | [] | [] | [] | 17,575 | 4 |
ENSG00000211781 | TRAV7 | T cell receptor alpha variable 7 | [
"A0A075B6U4"
] | 14 | 21782993-21783503 | Evidence at transcript level | No human protein/transcript evidence | No human protein/transcript evidence | Evidence at transcript level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | null | Cluster 12: Bone cancer - Neuronal signaling | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 17,577 | 8 |
ENSG00000211782 | TRAV8-1 | T cell receptor alpha variable 8-1 | [
"A0A0A6YYK1"
] | 14 | 21797287-21797886 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 7 | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in many | 43 | 0 | 0 | 0 | [] | [] | [] | 17,578 | 2 |
ENSG00000211783 | TRAV9-1 | T cell receptor alpha variable 9-1 | [
"A0A075B6T8"
] | 14 | 21811502-21811977 | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | null | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 17,579 | 5 |
ENSG00000211785 | TRAV12-1 | T cell receptor alpha variable 12-1 | [
"A0A0B4J245"
] | 14 | 21841240-21841774 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [] | [] | [
"Predicted intracellular proteins",
"T-cell receptor genes"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 27: T-cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enriched | Detected in some | 7 | Cancer enriched | Detected in single | 211 | Low cancer specificity | Detected in many | null | Not detected | Not detected | null | Group enriched | Detected in many | 71 | 0 | 0 | 0 | [] | [] | [] | 17,581 | 9 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.